About 1 result found for searched term "Ulocuplumab" (0.438 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24637 | Ulocuplumab | CXCR |
| BMS 936564; MDX 1338; Anti-Human CXCR4 Recombinant Antibody | ||
| Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
